Manipal Hospitals’ acquisition-led expansion is entering a key phase, with Jefferies initiating coverage with a Buy rating and Rs 870 target. The brokerage expects strong earnings growth, driven by the turnaround of Sahyadri Hospitals, new bed additions, higher utilisation and operating leverage. However, execution risks at Sahyadri and intensifying competition in Bengaluru remain key concerns for the investment case.
Market Samachar is a news aggregator. This article was originally published by Stocks-Markets-Economic Times. Tap the button above to read the full story on their site.